Engineered nanomaterials (ENMs) may decrease insulin sensitivity and damage pancreatic beta (β)‐cells, thus changing glucose homeostasis, which might lead to type 2 diabetes mellitus (T2DM) (Priyam et al., 2018). This evidence concerns the gene INS and type 2 diabetes mellitus.